Category: Healthcare Law

Cellceutix Wishes Shareholders Happy Holidays, Prepares for 2017 Focused on Partnerships

Cellceutix Corporation, , a clinical stage biopharmaceutical company developing innovative therapies with dermatology, oncology, anti-inflammatory, and antibiotic applications, would like to wish all Cellceutix shareholders, their families and friends a happy and healthy holiday season. In 2016, Cellceutix remained extremely transparent in keeping shareholders current on developments, including comprehensive updates via news releases and corporate presentations covering the status of clinical trials and anticipated milestones pertaining to those trials for 2017.

Study shows fewer people skip the doctor because of cost concerns after Obamacare was passed

A new report published by the Commonwealth Fund this week highlighted a variety of aspects of the insurance coverage gains made after Obamacare was passed, including a sizable decrease in the number of people who say they skipped going to the doctor because of cost concerns. In 2013, before the law had gone fully into effect, 20 percent of adults said they had forgone seeking medical treatment because of the cost.

Activists Defend ACA, March To Republican Party Headquarters

A small but boisterous group marched from Capital Community College to the Connecticut Republican Party headquarters on Pratt Street Tuesday afternoon, chanting, singing and protesting what they called “President-elect Donald Trump and his allies’ massive attack on every aspect of our families’ health care.” Once they arrived at the statewide GOP headquarters about 5:30 p.m., organizer Dan Durso rang the bell to the GOP office several times, but no one answered.

Legal Haze Clouds Cannabis For Pets

… client’s written consent is needed for any unorthodox treatment,” the memo stated. The Washington State Department of Health staffs the state’s Veterinary Board of Governors. The Department’s home page for veterinarians simply states, “The law …

Texas officially kicking Planned Parenthood out of Medicaid

After more than a year of delays , Texas is officially kicking Planned Parenthood out of the state’s Medicaid program. In a move that could affect thousands of low-income women, state health officials on Tuesday delivered a final legal notice to defund the organization from the Medicaid program through which it provides family planning and women’s health services to the poor.

Good News for Disabled Individuals at the End of 2016

As of December 19, 2016, the two year anniversary of enactment of the federal law that authorized states to create the programs, Virginia’s ABLEnow program has gone live. The program permits eligible disabled individuals to invest up to $14,000 a year without endangering their Medicaid and Supplemental Security Income benefits.

Trump immigration plan could cost the U.S. billions

President-elect Donald Trump’s vow to overturn an executive order that provides temporary protection from deportation to undocumented immigrants who were brought to the U.S. as children could cost the country tens of billions of dollars, a new study finds. Put in place by President Obama six years ago, the Deferred Action for Childhood Arrivals program has helped hundreds of thousands of young people – known as the DREAMers – come out from the shadows and get valid driver’s licenses, enroll in college and legally secure jobs.

Combination therapy holds great promise to clear precancerous skin lesions

A combination of two FDA-approved drugs – a topical chemotherapy and an immune-system-activating compound – was able to rapidly clear actinic keratosis lesions from patients participating in a clinical trial. Standard treatment for this common skin condition, which can lead to the development of squamous cell carcinoma, takes up to a month and can elicit several unpleasant side effects.

California push to cover illegals under Obamacare may fail

Time is running out for the administration to approve California’s push to allow illegal immigrants to use its Obamacare exchange, likely dooming the effort as President Obama prepares to hand the reins over to President-elect Donald Trump. The 2010 health law specifically banned illegal immigrants from signing up for Obamacare, with Capitol Hill Democrats fearing at the time that it was too politically charged.

California push to cover illegals under Obamacare may fail

Time is running out for the administration to approve California’s push to allow illegal immigrants to use its Obamacare exchange, likely dooming the effort as President Obama prepares to hand the reins over to President-elect Donald Trump. The 2010 health law specifically banned illegal immigrants from signing up for Obamacare, with Capitol Hill Democrats fearing at the time that it was too politically charged.

The new OMB’s director’s first order of business? Standing up to Trump.

AS THE federal government has grown, so has the power and responsibility of the White House-based agency charged with keeping tabs on spending, revenue and regulation. The director of that agency, the Office of Management and Budget, is much more than the president’s bean-counter; he or she is a key player on policy, as well as, traditionally, the voice of fiscal responsibility both within the executive branch and in the public arena.

FDA Drops Boxed Warning From Chantix Label

… be observed for the occurrence of such symptoms and should be instructed to discontinue varenicline and contact a health care provider if they experience such symptoms. The E valuating A dverse Events in a GL obal Smoking C E ssation S tudy (EAGLES) …

This drugmaker is taking an unprecedented approach to getting its cancer treatment approved

As researchers look for new approaches for tough-to-treat cancer, many are looking into genetics – more specifically, they’re looking at the type of genetic mutations found in cancerous tumors. One company in particular, called Loxo Oncology is building drugs that act on those mutations, so that the type of cancer someone has wouldn’t matter so much as the genetic information gleaned from sequencing the tumor.

Tetraphase Pharmaceuticals Provides Regulatory and Clinical Update for Eravacycline

Tetraphase Pharmaceuticals, Inc. , a clinical stage biopharmaceutical company developing novel antibiotics to treat life-threatening multidrug-resistant infections, today provided a regulatory and clinical development update for eravacycline, the Company’s lead antibiotic candidate with potent activity against MDR pathogens, which is being developed for the treatment of serious and life-threatening bacterial infections. During the second half of 2017, Tetraphase plans to submit a Marketing Authorization Application to the European Medicines Agency for IV eravacycline for the treatment of cIAI.

Trump action on health care could cost Planned Parenthood

One of President-elect Donald Trump’s first, and defining, acts next year could come on Republican legislation to cut off taxpayer money from Planned Parenthood. Trump sent mixed signals during the campaign about the 100-year-old organization, which provides birth control, abortions and various women’s health services.